Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- PMID: 37611136
- DOI: 10.1056/NEJMx230004
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Erratum for
-
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources